Brazil, Risk Management, Compliance

[Event] The Brazil Summit on Anti-Corruption, Integrity & ESG - May 22nd - 23rd, São Paulo, Brazil

American Conference Institute (ACI) on 3/27/2024

Hosted by American Conference Institute, the 14th Annual Summit on Anti-Corruption, Integrity & ESG returns to Brazil for another groundbreaking year to discuss the current high-stakes dilemmas impacting your organization....more

[Webinar] Anti-Corruption Brazil – FCPA Compliance and Enforcement in Brazil: DOJ and SEC Alumni Provide Critical Updates and the...

American Conference Institute (ACI) on 3/13/2023

American Conference Institute’s expert faculty of DOJ and SEC alumni will update you with the most recent developments and risk factors confronting industry in Brazil and will lay out practical takeaways for satisfying the...more

[Webinar] Third Party Due Diligence in LATAM - January 19th, 12:00 pm - 1:30 pm CT

Society of Corporate Compliance and Ethics... on 1/10/2023

Learning objectives: - The importance of third-party due diligence - Challenges of third-party due diligence in LATAM - How to establish a proper due diligence process: key steps, identifying risk based categories. ...more

Lessons Learned: Foster Wheeler FCPA Settlement Underscores Danger of Third-Party Risks (Part III of III)

The Volkov Law Group on 6/30/2021

We all know and hear about third-party risks – over and over again. Despite this recurring theme, organizations continue to pay the price for failing to address third-party issues. It does not take a rocket scientist to...more

Long-Running Corruption Scheme Exposed in Brazil: Operation "Exposed Invoice" Provides Continuous Improvement Opportunity for...

Troutman Pepper on 4/17/2017

A massive scheme involving medical products sales to Brazilian public entities has led to recent high-profile arrests. The events highlight the importance to a well-functioning compliance program of keeping up with new...more

FCPA Recidivists: Zimmer Biomet (Part I of II)

The Volkov Law Group on 1/26/2017

The drug and medical device industries have been taking it on the FCPA chin for years. The risk factors in the international marketplace are significant – healthcare professionals are normally government employees; government...more